AMN Healthcare Appoints New CLO, Director Changes

Ticker: AMN · Form: 8-K · Filed: 2024-11-12T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, board-of-directors, executive-appointment

Related Tickers: AMN

TL;DR

AMN Healthcare shakes up leadership: new CLO Brenda Williams starts Nov 11, director David Johnson joins board, Michael McGovern departs.

AI Summary

AMN Healthcare Services, Inc. announced on November 9, 2024, the departure of director Michael J. McGovern and the election of new director David R. Johnson. The company also appointed Brenda J. Williams as Chief Legal Officer and General Counsel, effective November 11, 2024. These changes are part of the company's ongoing governance and leadership adjustments.

Why It Matters

Changes in key leadership roles like Chief Legal Officer and board composition can signal shifts in company strategy or risk management approach.

Risk Assessment

Risk Level: low — The filing reports routine changes in directorship and executive appointments, which are common corporate events.

Key Players & Entities

FAQ

Who has departed from the board of directors at AMN Healthcare Services, Inc.?

Michael J. McGovern has departed from the board of directors.

Who has been elected as a new director for AMN Healthcare Services, Inc.?

David R. Johnson has been elected as a new director.

Who has been appointed as the new Chief Legal Officer and General Counsel?

Brenda J. Williams has been appointed as the new Chief Legal Officer and General Counsel.

When is Brenda J. Williams' appointment as Chief Legal Officer and General Counsel effective?

Brenda J. Williams' appointment is effective November 11, 2024.

What is the exact date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is November 9, 2024.

From the Filing

0000950142-24-002717.txt : 20241112 0000950142-24-002717.hdr.sgml : 20241112 20241112080013 ACCESSION NUMBER: 0000950142-24-002717 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241109 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 241443479 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 eh240555965_8k.htm FORM 8-K FORM 8-K false 0001142750 0001142750 2024-11-09 2024-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2024   AMN HEALTHCARE SERVICES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-16753 06-1500476 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)       2999 Olympus Boulevard , Suite 500 Dallas , Texas 75019 (Address of principal executive offices) (Zip Code)   ( 866 ) 871-8519 (Registrant’s Telephone Number, Including Area Code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   AMN   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐               Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On November 9, 2024, Douglas D. Wheat, the Chairman of the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) notified the Company and the Board that he will not stand for re-election at the Company’s 2025 annual meeting of

View on Read The Filing